Firebrick Pharma LimitedASX: FRE

Firebrick Pharmas Phase 3 Trial of Nasodine Resumes

Mar 21, 2023 at 2:03 AM UTC · Issued by Firebrick Pharma Limited

Firebrick Pharma Ltd has released a press release.

View Attachment